FindTrial
Sign In

Study on the application of A2 subtype genotyping in transplantation and blood transfusion

Study on the application of A2 subtype genotyping in transplantation and blood transfusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028016
Enrollment
Unknown
Registered
2019-12-08
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood group subtype

Interventions

Case series:None

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Serological subtype

Exclusion criteria

Exclusion criteria: Gene non-subtype

Design outcomes

Primary

MeasureTime frame
Blood type;—

Countries

China

Contacts

Public ContactZhao Yuan

Tianjin First Central Hospital

1554538937@qq.com+86 18630927958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026